Breast Cancer

70-gene signature not cost-effective in breast cancer

(HealthDay)—For patients with node-negative breast cancer (NNBC), the 70-gene signature is unlikely to be cost-effective for guiding adjuvant chemotherapy decision making, according to a study published ...

Oct 18, 2014
popularity 3 / 5 (2) | comments 0

What to know if breast cancer runs in your family

Breast cancer is the second leading cause of death from cancer in women. A woman's lifetime risk of developing breast cancer is 12 percent (1 of every 8 women). Breast cancer risk is higher among women whose close blood relatives ...

Oct 07, 2014
popularity 5 / 5 (1) | comments 0

Latest Spotlight News